HIGHER BASELINE INFLAMMATORY BURDEN IS ASSOCIATED WITH WORSE PROGNOSIS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE UNDERGOING CORONARY STENTING  by Ghasemzadeh, Nima et al.
    
 i2 SUMMIT   
A191.E1785 
JACC March 9, 2010
Volume 55, issue 10A
HIGHER BASELINE INFLAMMATORY BURDEN IS ASSOCIATED WITH WORSE PROGNOSIS IN PATIENTS 
WITH STABLE CORONARY ARTERY DISEASE UNDERGOING CORONARY STENTING
i2 Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 9:30 a.m.-10:30 a.m.
Session Title: DES I and Acute Coronary Syndromes
Abstract Category: PCI - DES
Presentation Number: 2501-516
Authors: Nima Ghasemzadeh, Zohreh Forghani, Konstantinos Aznaouridis, Paddi K. Reddy, Christine DeStareck, Craig Hooper, Arshed A. Quyyumi, 
Kreton Mavromatis, Emory University, Atlanta, GA, Atlanta VA Medical Center, Decatur, GA
Individual inflammatory markers (IMs) have been variably associated with outcomes in patients with stable coronary artery disease (CAD). 
However, data is lacking on the effect of inflammatory burden, measured as a composite of major pathologically-important IMs, on clinical 
outcomes in these patients. We sought to investigate this association in patients undergoing elective coronary stenting. Circulating IMs (CRP, 
CD40L, MCP-1, IL-6, IL-10, MMP-3) were measured before stenting and patients were followed for death or myocardial infarction (MI) for 28 
months (range 4-61). 207 patients (male: 84%; age: 61+10 years; DM: 44%; DES: 90%) were studied. Univariate analysis including clinical 
factors and all IMs showed CRP, IL-6, and IL-10 and sCD40L levels as predictors of death or MI (p-value: 0.009, 0.003, 0.01, and 0.01 
respectively). Patients were then divided into two groups based on whether they had low burden (0, 1, or 2 IMs > median) or high burden (3 
or 4 IMs > median) of inflammation. Patients with a higher IM burden, had the worst prognosis (log- rank p< 0.001). Cox-proportional hazard 
analysis showed IM burden to be an independent predictor of prognosis (adjusted HR of having > 2 high IMs = 15.4, p = 0.001). In conclusion, 
a higher IM burden (>2 high IMs) before stenting is associated with a worse prognosis in patients with stable CAD. A scoring system based 
on measurement of multiple IMs rather than any single one might be useful in risk stratification and outcome prediction of these patients.
